Literature DB >> 29372325

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study.

A Uhlmann1,2, B Bandelow3, D J Stein1, S Bloch3, K R Engel3, U Havemann-Reinecke3,4, Dirk Wedekind5.   

Abstract

Although depression and anxiety disorders are common comorbid conditions in alcohol dependence, few structural brain imaging studies have compared alcohol-dependent subjects with and without such comorbidity. In the current study, brain scans of 35 alcohol-dependent with and 40 individuals without diagnosis of a comorbid ICD-10 depressive or anxiety disorder receiving detoxification inpatient treatment were evaluated. Thickness and volumes of automatically segmented neuroanatomical structures were measured in FreeSurfer. Furthermore, associations of brain structure with biological markers and clinical severity markers of alcohol dependence were assessed. Despite comparable addiction severity, the non-comorbid group had evidence of higher cytotoxic effects of alcohol use on hepatic and haematological markers, and showed significantly smaller volumes of total cerebral, and cerebellar grey matter. Similarly, they showed unexpected smaller hippocampal and nucleus accumbens volumes, and thinner frontal, temporal and occipital cortices. Smaller brain volumes correlated with increased markers of hepatic and haematological dysfunction, and with longer duration of alcohol dependence in the non-comorbid group. Evidence of higher biomarkers of alcohol use may be indicative of more severe alcohol dependence or higher vulnerability to ethanol toxicity in this group. Furthermore, psychopathology-related drug treatment, which occurred in 53% of the comorbid group over the recent years, or tissue inflammation may have a moderate effect on the grade of cerebral atrophy in alcohol-dependent patients. Longitudinal studies are needed to investigate this issue more fully.

Entities:  

Keywords:  Alcoholism; Cortex; Erythrocyte measures; Liver enzymes; Subcortical volumes

Mesh:

Substances:

Year:  2018        PMID: 29372325     DOI: 10.1007/s00406-018-0870-x

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  61 in total

Review 1.  Truth or consequences: the validity of self-report data in health services research on addictions.

Authors:  F K Del Boca; J A Noll
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

2.  Cortical gray matter loss in treatment-naïve alcohol dependent individuals.

Authors:  G Fein; V Di Sclafani; V A Cardenas; H Goldmann; M Tolou-Shams; D J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2002-04       Impact factor: 3.455

3.  Neuroprotective effects of antidepressant and mood stabilizing drugs.

Authors:  L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

4.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

5.  Inflammatory markers in major depression and melancholia.

Authors:  M Rothermundt; V Arolt; M Peters; H Gutbrodt; J Fenker; A Kersting; H Kirchner
Journal:  J Affect Disord       Date:  2001-03       Impact factor: 4.839

6.  Talk is cheap: measuring drinking outcomes in clinical trials.

Authors:  T F Babor; K Steinberg; R Anton; F Del Boca
Journal:  J Stud Alcohol       Date:  2000-01

7.  Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany.

Authors:  U Schneider; A Altmann; M Baumann; J Bernzen; B Bertz; U Bimber; T Broese; A Broocks; W Burtscheidt; K F Cimander; P Degkwitz; M Driessen; H Ehrenreich; E Fischbach; H Folkerts; H Frank; D Gurth; U Havemann-Reinecke; W Heber; J Heuer; A Hingsammer; S Jacobs; H Krampe; W Lange; T Lay; M Leimbach; M R Lemke; M Leweke; A Mangholz; W Massing; R Meyenberg; J Porzig; T Quattert; C Redner; G Ritzel; J D Rollnik; R Sauvageoll; D Schläfke; G Schmid; H Schröder; U Schwichtenberg; D Schwoon; J Seifert; I Sickelmann; C F Sieveking; C Spiess; H H Stiegemann; R Stracke; H D Straetgen; P Subkowski; R Thomasius; H Tretzel; L J Verner; J Vitens; T Wagner; S Weirich; I Weiss; T Wendorff; T Wetterling; B Wiese; J Wittfoot
Journal:  Alcohol Alcohol       Date:  2001 May-Jun       Impact factor: 2.826

8.  Linear CT-scan measurements in alcohol-dependent patients with and without delirium tremens.

Authors:  M Maes; E Vandoolaeghe; J Degroote; C Altamura; C Roels; P Hermans
Journal:  Alcohol       Date:  2000-02       Impact factor: 2.405

9.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

10.  Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders.

Authors:  M G Kushner; K J Sher; D J Erickson
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

View more
  3 in total

1.  Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders.

Authors:  Timothy C Durazzo; Linh-Chi Nguyen; Dieter J Meyerhoff
Journal:  Alcohol Alcohol       Date:  2020-06-25       Impact factor: 2.826

2.  Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study.

Authors:  Margaret R Flanigan; Sarah K Royse; David P Cenkner; Katelyn M Kozinski; Clara J Stoughton; Michael L Himes; Davneet S Minhas; Brian Lopresti; Meryl A Butters; Rajesh Narendran
Journal:  Transl Psychiatry       Date:  2021-05-01       Impact factor: 7.989

3.  Alcohol Use and Prefrontal Cortex Volume Trajectories in Young Adults with Mood Disorders and Associated Clinical Outcomes.

Authors:  Dylan E Kirsch; Valeria Tretyak; Vanessa Le; Ansley Huffman; Kim Fromme; Stephen M Strakowski; Elizabeth T C Lippard
Journal:  Behav Sci (Basel)       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.